دوره 6، شماره 3 - ( 5-1397 )                   جلد 6 شماره 3 صفحات 53-45 | برگشت به فهرست نسخه ها

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Namazi F, Hadi N, Moghimi M, Eshaghiyan A, Nateghi B. Down-regulation of miR-193b-3p and miR-376a-3p in Chronic Lymphocytic Leukemia. Res Mol Med (RMM) 2018; 6 (3) :45-53
URL: http://rmm.mazums.ac.ir/article-1-288-fa.html
Down-regulation of miR-193b-3p and miR-376a-3p in Chronic Lymphocytic Leukemia. Research in Molecular Medicine. 1397; 6 (3) :45-53

URL: http://rmm.mazums.ac.ir/article-1-288-fa.html


چکیده:   (3756 مشاهده)
Background: Chronic lymphocytic leukemia (CLL) is the most common adult human leukemia. Studies revealed that microRNAs (miRNAs) can function as oncogenes or tumor suppressors in CLL and that the expression of miRNAs, such as miR-193b-3p and miR-376a-3p change in several diseases. We aimed to elucidate the changes in miR-193b-3p and miR-376a-3p expression in CLL and determine their potential as diagnostic biomarkers for this disease.
 Materials and methods: We investigated miR-193b-3p and miR-376a-3p expression by quantitative real-time PCR in peripheral blood mononuclear cells of 30 patients with CLL and 30 healthy individuals. Moreover, in silico molecular enrichment analysis was conducted on predicted and validated targets of miR-193b-3p and miR-376a-3p from the miRecords and miRTarBase databases.
Results: The expression of miR-193b-3p and miR-376a-3p was significantly different between the two groups (P<0.0001 and P < 0.0001, respectively).
Conclusion: Based on these findings, miR-193b-3p and miR-376a-3p could be novel biomarkers for the early diagnosis of CLL and could be used to design new CLL control strategies.
متن کامل [PDF 312 kb]   (1235 دریافت)    
نوع مطالعه: پژوهشي | موضوع مقاله: هماتولوژی و آنکولوژی
انتشار: 1397/5/24

ارسال نظر درباره این مقاله : نام کاربری یا پست الکترونیک شما:
CAPTCHA

بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.

کلیه حقوق این وب سایت متعلق به Research in Molecular Medicine می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

© 2024 CC BY-NC 4.0 | Research in Molecular Medicine

Designed & Developed by : Yektaweb